Strengthening Capacity for the Development of Theranostic Peptide Radiopharmaceuticals
Project Type
Technical Cooperation ProjectProject Code
IRA6012
Approved Date
1 January 2022Project Status
ActiveObjectives
To increase life expectancy in cancer patients by strengthening capacity for the development of radiolabelled theranostic peptide radiopharmaceuticals.